Sharp Therapeutics Corp.

1.37

CAD

0.00

(0.00%)

-0.29EPS

75.33MMarket Cap

Income Statement (USD)

Income Statement API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -
- Cost of Revenue	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -
Gross Profit	- -	- -	- -
+ Other Operating Income	- -	- -	- -
- Operating Expenses	2	5	6
+ Selling, General & Admin	- -	- -	2
+ Research & Development	2	2	4
+ Other Operating Expense	- -	2	- -
Operating Income (Loss)	-2	-5	-6
- Non-Operating (Income) Loss	1	-1	1
+ Interest Expense, Net	- -	- -	- -
+ Interest Expense	- -	- -	- -
- Interest Income	- -	- -	- -
+ Other Non-Op (Income) Loss	1	-1	- -
Pretax Income	-4	-3	-6
- Income Tax Expense (Benefit)	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -
Income (Loss) from Cont Ops	-4	-3	-6
- Net Extraordinary Losses (Gains)	- -	- -	- -
+ Discontinued Operations	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -
Income (Loss) Incl. MI	-4	-3	-6
- Minority Interest	- -	- -	- -
Net Income, GAAP	-4	-3	-6
- Preferred Dividends	- -	- -	- -
- Other Adjustments	- -	- -	- -
Net Income Avail to Common, GAAP	-4	-3	-6
EBIT	2	-3	-6
EBITDA	2	-2	-5
EBITDA Margin (%)	- -	- -	- -
EBITA	- -	- -	- -
Gross Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Sales per Employee	- -	- -	- -
Dividend per Share	- -	- -	- -
Depreciation Expense	- -	- -	- -
Basic Weighted Avg Shares	28	9	30
Basic EPS, GAAP	-0.13	-0.36	-0.21
Basic EPS from Cont Ops	-0.13	-0.36	-0.21
Diluted Weighted Avg Shares	28	9	30
Diluted EPS, GAAP	-0.13	-0.36	-0.21
Diluted EPS from Cont Ops	-0.13	-0.36	-0.21

Balance Sheet (USD)

Balance Sheet API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	- -	4	1
+ Cash, Cash Equivalents & STI	- -	3	1
+ Cash & Cash Equivalents	- -	3	1
+ ST Investments	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -
+ Inventories	- -	- -	- -
+ Raw Materials	- -	- -	- -
+ Work In Process	- -	- -	- -
+ Finished Goods	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -
+ Other Inventory	- -	- -	- -
+ Other ST Assets	- -	- -	- -
+ Misc ST Assets	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -
Total Noncurrent Assets	1	1	1
+ Property, Plant & Equip, Net	1	1	1
+ Property, Plant & Equip	2	2	2
- Accumulated Depreciation	- -	1	1
+ LT Investments & Receivables	- -	- -	- -
+ LT Investments	- -	- -	- -
+ LT Receivables	- -	- -	- -
+ Other LT Assets	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -
+ Goodwill	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -
+ Misc LT Assets	- -	- -	- -
Total Assets	2	5	2
+ Payables & Accruals	- -	1	1
+ Accounts Payable	- -	- -	- -
+ Accrued Taxes	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -
+ Other Payables & Accruals	- -	- -	1
+ ST Debt	6	- -	- -
+ ST Borrowings	6	- -	- -
+ ST Finance Leases	- -	- -	- -
+ Other ST Liabilities	1	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Misc ST Liabilities	1	- -	- -
Total Current Liabilities	8	1	1
+ LT Debt	3	1	1
+ LT Borrowings	1	- -	- -
+ LT Finance Leases	1	1	1
+ Other LT Liabilities	3	- -	- -
+ Accrued Liabilities	- -	- -	- -
+ Pension Liabilities	- -	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Misc LT Liabilities	3	- -	- -
Total Noncurrent Liabilities	5	1	1
Total Liabilities	13	2	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Share Capital & APIC	5	22	26
+ Common Stock	5	22	25
+ Additional Paid in Capital	1	1	1
- Treasury Stock	- -	- -	- -
+ Retained Earnings	-17	-20	-26
+ Other Equity	- -	- -	- -
Equity Before Minority Interest	-11	3	- -
+ Minority/Non Controlling Interest	- -	- -	- -
Total Equity	-11	3	- -
Total Liabilities & Equity	2	5	2
Shares Outstanding	28	28	30
Number of Employees	- -	- -	- -
Capital Leases - Total	1	1	1
Net Debt	7	-3	-1
Net Debt to Equity	-58.33	-134.82	541.69
Tangible Common Equity Ratio	-742.5	56.76	-9.05
Current Ratio	0.06	5.1	1.06
Cash Conversion Cycle	- -	- -	- -

Cash Flow Statement (USD)

Cash Flow Statement API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-4	-3	-6
+ Depreciation & Amortization	- -	- -	- -
+ Non-Cash Items	1	-1	1
+ Stock-Based Compensation	- -	- -	- -
+ Deferred Income Taxes	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -
+ Other Non-Cash Adj	1	-1	1
+ Chg in Non-Cash Work Cap	- -	- -	- -
+ (Inc) Dec in Accts Receiv	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	- -
+ Inc (Dec) in Other	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Operating Activities	-2	-4	-5
+ Change in Fixed & Intang	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -
+ Cash (Repurchase) of Equity	2	5	- -
+ Increase in Capital Stock	2	5	- -
+ Decrease in Capital Stock	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -
+ Cash for JVs	- -	- -	- -
+ Other Investing Activities	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Investing Activities	- -	- -	- -
+ Dividends Paid	- -	- -	- -
+ Net Cash From Debt	- -	2	- -
+ Cash From Debt	- -	2	- -
+ Repayments of Debt	- -	- -	- -
+ Other Financing Activities	- -	- -	3
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Financing Activities	2	7	2
Effect of Foreign Exchange Rates	- -	- -	- -
Net Changes in Cash	- -	3	-3
EBITDA	2	-2	-5
EBITDA Margin (%)	- -	- -	- -
Free Cash Flow	-2	-4	-5
Net Cash Paid for Acquisitions	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -
Free Cash Flow to Equity	-2	-2	-5
Free Cash Flow per Basic Share	-0.07	-0.4	-0.16
Price/Free Cash Flow	-11.37	- -	-11.36
Cash Flow to Net Income	0.55	1.11	0.78
Capital Expenditures	- -	- -	- -